Who owns VIRACTA THERAPEUTICS INC?
- Ticker: VIRX
- CUSIP Number: 92765f108
Tip: Access positions for across all investors
Analyze quarterly positions in Viracta Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Viracta Therapeutics stock
Who bought or sold VIRACTA THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Citadel Advisors | 1.6M | $262k | 7% | Dec 2024 |
|
Vanguard Group | 289k | $47k | -70% | Dec 2024 |
|
Aisling Capital Management | 289k | $46k | 0% | Dec 2024 |
|
Renaissance Technologies | 286k | $46k | 17% | Dec 2024 |
|
BlackRock | 235k | $38k | 0% | Dec 2024 |
|
Geode Capital Management | 224k | $36k | -10% | Dec 2024 |
|
Virtu Financial | 128k | $21k | 100% | Dec 2024 |
|
UBS Group | 93k | $15k | 97981% | Dec 2024 |
|
Hrt Financial | 83k | $13k | -40% | Dec 2024 |
|
State Street Corporation | 66k | $11k | 0% | Dec 2024 |
|
Jane Street | 55k | $8.9k | 100% | Dec 2024 |
|
United Capital Financial Advisers | 43k | $6.9k | 0% | Dec 2024 |
|
Northern Trust | 38k | $6.1k | 0% | Dec 2024 |
|
Morgan Stanley | 36k | $5.8k | 18% | Dec 2024 |
|
Integrys Wealth Advisors | 25k | $5.3k | 0% | Dec 2024 |
|
Two Sigma Securities | 17k | $2.7k | 100% | Dec 2024 |
|
Wealthtrust Axiom | 16k | $2.6k | 0% | Dec 2024 |
|
XTX Topco | 15k | $2.4k | 46% | Dec 2024 |
|
Trust Co Of Toledo Na | 12k | $2.0k | 0% | Dec 2024 |
|
Baader Bank | 11k | $1.6k | 100% | Dec 2024 |
|
Planning Capital Management Corp | 7.3k | $1.7k | 0% | Sep 2024 |
|
Dunhill Financial | 5.0k | $1.2k | 100% | Sep 2024 |
|
MAI Wealth Advisors | 4.0k | $646.898000 | 100% | Dec 2024 |
|
RP Management | 3.7k | $851.000000 | 0% | Dec 2024 |
|
IAG Wealth Partners | 3.0k | $483.000000 | 0% | Dec 2024 |
|
Bank of America Corporation | 1.1k | $178.491200 | -93% | Dec 2024 |
|
Oarsman Capital | 1.0k | $161.000000 | 0% | Dec 2024 |
|
Jpmorgan Chase & Co | 721.00 | $116.008900 | 0% | Dec 2024 |
|
Indiana Trust & Investment Management | 200.00 | $32.000000 | 0% | Dec 2024 |
|
SBI Securities | 180.00 | $28.998000 | 100% | Dec 2024 |
|
Wells Fargo & Company | 171.00 | $27.992700 | 0% | Dec 2024 |
|
Parallel Advisors | 8.00 | $1.000000 | 0% | Dec 2024 |
|
Addison Advisors | 4.00 | $1.000000 | 0% | Dec 2024 |
|
Who sold out of Viracta Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Samsara BioCapital | Sep 2024 | 690k | $160k |
Stonepine Capital Management | Sep 2024 | 500k | $116k |
Laurion Capital Management | Sep 2024 | 332k | $77k |
Landscape Capital Management | Sep 2024 | 68k | $16k |
Goldman Sachs Group | Sep 2024 | 27k | $6.3k |
Royal Bank of Canada | Sep 2024 | 20k | $5.0k |
Colony | Sep 2024 | 14k | $3.2k |
Tower Research Capital | Sep 2024 | 14k | $3.2k |
Acadian Asset Management | Sep 2024 | 11k | $2.0k |
Jones Financial Companies, L.L | Sep 2024 | 1.0k | $222.000000 |